262 related articles for article (PubMed ID: 19520702)
1. Pharmacokinetic models for propofol--defining and illuminating the devil in the detail.
Absalom AR; Mani V; De Smet T; Struys MM
Br J Anaesth; 2009 Jul; 103(1):26-37. PubMed ID: 19520702
[TBL] [Abstract][Full Text] [Related]
2. The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data.
Masui K; Upton RN; Doufas AG; Coetzee JF; Kazama T; Mortier EP; Struys MM
Anesth Analg; 2010 Aug; 111(2):368-79. PubMed ID: 19861357
[TBL] [Abstract][Full Text] [Related]
3. Allometric or lean body mass scaling of propofol pharmacokinetics: towards simplifying parameter sets for target-controlled infusions.
Coetzee JF
Clin Pharmacokinet; 2012 Mar; 51(3):137-45. PubMed ID: 22316280
[TBL] [Abstract][Full Text] [Related]
4. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.
Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S
Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic responses during induction: comparison of Marsh and Schnider pharmacokinetic models.
Yang XY; Zhou ZB; Yang L; Zhou X; Niu LJ; Feng X
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):32-40. PubMed ID: 25500489
[TBL] [Abstract][Full Text] [Related]
6. Effect site concentration during propofol TCI sedation: a comparison of sedation score with two pharmacokinetic models.
Barakat AR; Sutcliffe N; Schwab M
Anaesthesia; 2007 Jul; 62(7):661-6. PubMed ID: 17567340
[TBL] [Abstract][Full Text] [Related]
7. TCI : Target controlled infusion, or totally confused infusion? Call for an optimised population based pharmacokinetic model for propofol.
Enlund M
Ups J Med Sci; 2008; 113(2):161-70. PubMed ID: 18509810
[TBL] [Abstract][Full Text] [Related]
8. Predictive performance of a new pharmacokinetic model for propofol in underweight patients during target-controlled infusion.
Yi JM; Doh I; Lee SH; Kim SY; Lee YH; Lee EK; Lee SH; Choi BM; Noh GJ
Acta Anaesthesiol Scand; 2019 Apr; 63(4):448-454. PubMed ID: 30690713
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the performance of the Marsh model in effect site mode for target controlled infusion of propofol during the maintenance phase of general anaesthesia in an unselected population of neurosurgical patients.
Cowley NJ; Hutton P; Clutton-Brock TH
Eur J Anaesthesiol; 2013 Oct; 30(10):627-32. PubMed ID: 23962821
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic analysis of propofol in underweight patients under general anaesthesia.
Park JH; Choi SM; Park JH; Lee KH; Yun HJ; Lee EK; Choi BM; Noh GJ
Br J Anaesth; 2018 Sep; 121(3):559-566. PubMed ID: 30115253
[TBL] [Abstract][Full Text] [Related]
11. The effective effect-site propofol concentration for induction and intubation with two pharmacokinetic models in morbidly obese patients using total body weight.
Echevarría GC; Elgueta MF; Donoso MT; Bugedo DA; Cortínez LI; Muñoz HR
Anesth Analg; 2012 Oct; 115(4):823-9. PubMed ID: 22956531
[TBL] [Abstract][Full Text] [Related]
12. Predictive performance of the modified Marsh and Schnider models for propofol in underweight patients undergoing general anaesthesia using target-controlled infusion.
Lee YH; Choi GH; Jung KW; Choi BH; Bang JY; Lee EK; Choi BM; Noh GJ
Br J Anaesth; 2017 Jun; 118(6):883-891. PubMed ID: 28541533
[TBL] [Abstract][Full Text] [Related]
13. Comparison of propofol pharmacokinetic and pharmacodynamic models for awake craniotomy: A prospective observational study.
Soehle M; Wolf CF; Priston MJ; Neuloh G; Bien CG; Hoeft A; Ellerkmann RK
Eur J Anaesthesiol; 2015 Aug; 32(8):527-34. PubMed ID: 25774459
[TBL] [Abstract][Full Text] [Related]
14. Individualizing propofol dosage: a multivariate linear model approach.
Rocha C; Mendonça T; Silva ME; Gambús P
J Clin Monit Comput; 2014 Dec; 28(6):525-36. PubMed ID: 24072471
[TBL] [Abstract][Full Text] [Related]
15. Comparison of plasma compartment versus two methods for effect compartment--controlled target-controlled infusion for propofol.
Struys MM; De Smet T; Depoorter B; Versichelen LF; Mortier EP; Dumortier FJ; Shafer SL; Rolly G
Anesthesiology; 2000 Feb; 92(2):399-406. PubMed ID: 10691226
[TBL] [Abstract][Full Text] [Related]
16. Performance of TCI Propofol Using the Schnider Model for Cardiac Surgery on Cardiopulmonary Bypass-A Pilot Study.
Lee AKY; Kong AYH; Kong CF
J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):723-730. PubMed ID: 29225156
[TBL] [Abstract][Full Text] [Related]
17. Study of the time course of the clinical effect of propofol compared with the time course of the predicted effect-site concentration: Performance of three pharmacokinetic-dynamic models.
Coppens M; Van Limmen JG; Schnider T; Wyler B; Bonte S; Dewaele F; Struys MM; Vereecke HE
Br J Anaesth; 2010 Apr; 104(4):452-8. PubMed ID: 20190259
[TBL] [Abstract][Full Text] [Related]
18. External validation of the modified Marsh and Schnider models for medium-chain triglyceride propofol in target-controlled infusion anesthesia.
Lee S; Kang D; Song E; Yoo S; Jeong S
BMC Anesthesiol; 2024 Feb; 24(1):70. PubMed ID: 38395779
[TBL] [Abstract][Full Text] [Related]
19. The influence of target concentration, equilibration rate constant (ke0 ) and pharmacokinetic model on the initial propofol dose delivered in effect-site target-controlled infusion.
Glen JB; Engbers FH
Anaesthesia; 2016 Mar; 71(3):306-14. PubMed ID: 26682512
[TBL] [Abstract][Full Text] [Related]
20. Induction of general anaesthesia by effect-site target-controlled infusion of propofol: influence of pharmacokinetic model and ke0 value.
Thomson AJ; Morrison G; Thomson E; Beattie C; Nimmo AF; Glen JB
Anaesthesia; 2014 May; 69(5):429-35. PubMed ID: 24738800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
